differentiated thyroid carcinoma

You have access
Thyroid Uptake and Effective Half-Life of Radioiodine in Thyroid Cancer Patients at Radioiodine Therapy and Follow-Up Whole-Body Scintigraphy Either in Hypothyroidism or Under rhTSH
Robin Bacher, Melanie Hohberg, Markus Dietlein, Markus Wild, Carsten Kobe, Alexander Drzezga and Matthias Schmidt

Journal of Nuclear Medicine May 1, 2019, 60 (5) 631-637; DOI: https://doi.org/10.2967/jnumed.118.217638
You have access
A Matter of Controversy: Is Radioiodine Therapy Favorable in Differentiated Thyroid Carcinoma?
Matthias Schmidt, Rainer Görges, Alexander Drzezga and Markus Dietlein

Journal of Nuclear Medicine August 1, 2018, 59 (8) 1195-1201; DOI: https://doi.org/10.2967/jnumed.117.191338
You have access
TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer
Xue Yang, Jiao Li, Xiaoyi Li, Zhiyong Liang, Wen Gao, Jun Liang, Shujun Cheng and Yansong Lin

Journal of Nuclear Medicine February 1, 2017, 58 (2) 258-265; DOI: https://doi.org/10.2967/jnumed.116.180240
You have access
⁶⁸Ga-DOTATOC PET/CT in Patients with Iodine- and ¹⁸F-FDG–Negative Differentiated Thyroid Carcinoma and Elevated Serum Thyroglobulin
Ina Binse, Thorsten D. Poeppel, Marcus Ruhlmann, Samer Ezziddin, Rainer Görges, Amir Sabet, Karsten Beiderwellen, Andreas Bockisch and Sandra J. Rosenbaum-Krumme

Journal of Nuclear Medicine October 1, 2016, 57 (10) 1512-1517; DOI: https://doi.org/10.2967/jnumed.115.171942
You have access
Recurrent Disease in Juvenile Differentiated Thyroid Carcinoma: Prognostic Factors, Treatments, and Outcomes
Jasna Mihailovic, Katarina Nikoletic and Dolores Srbovan

Journal of Nuclear Medicine May 1, 2014, 55 (5) 710-717; DOI: https://doi.org/10.2967/jnumed.113.130450

Main menu

User menu

Search

differentiated thyroid carcinoma